The company will conduct the test runs by the end of this month to investigate whether the plant is maintaining GMP.
Additionally, the company will also verify its performance, efficiency, reliability and safety of the Azithromycin API manufacturing at JCM.
Following the successful completion of the test runs the company will initiate the GMP certification process.